EverHint – EMA 10/30 Crossover – Top 15 Buy and Top 5 Sell Signals for Aug 27, 2026
Excerpt: 20 signals (from 54 total). Technology leads (12). price range $7-$338. 1 with insider selling.
What This Signal Is
Detects fresh crossovers between the 10-day exponential moving average (EMA10) and the 30-day exponential moving average (EMA30), generating both buy and sell signals. Uses two EMAs instead of EMA + SMA, making it more responsive to price changes and better suited for capturing short-to-medium term momentum shifts.
Entry Criteria:
- Buy: EMA10 crosses above EMA30
- Sell: EMA10 crosses below EMA30
- Minimum ADV: $40M (liquidity filter)
- Earnings buffer: 7 days pre/post earnings
- Fresh crossover: Detected on today's close
Holding period: 1-4 weeks | Risk level: Medium
Market Context
Markets are displaying a constructive risk-on tone heading into August 27, 2026, with the Nasdaq leading the charge at +1.57% and the broader S&P 500 adding a solid +0.71%. This divergence between tech-heavy indices and the more measured Dow Jones gain of +0.20% signals that growth and momentum names are driving the day's strength. For EMA-based crossover strategies like the ema10/ema30 setup, this kind of trending, directional price action is favorable — short-term averages are more likely to maintain clean separation from longer-term averages, reducing the noise that typically degrades signal quality.
The VIX at 14.51, down nearly 5% on the session, reflects a notably calm volatility environment. Low implied volatility generally compresses intraday price ranges, which can mean that while trend signals are cleaner, the profit potential per swing may be more modest. Traders following EMA crossover signals should be mindful that tight ranges could limit follow-through on individual moves, making entry timing and position sizing particularly important to capture meaningful gains without overexposure.
Technology's dominance as the top sector aligns well with the Nasdaq's outperformance and suggests sector rotation is currently favoring growth over defensives. With 54 signals generated in this environment, the strategy is finding ample opportunities, likely concentrated where momentum is strongest. The combination of low volatility, positive trend direction, and tech leadership creates a broadly supportive backdrop for trend-following signals, though traders should remain alert to any sudden volatility expansion that could quickly invalidate short-term crossover setups.
🟢 Buy Signals (15 of 23 total)
Ranked by RSI (lower RSI for buy signals = more oversold)
| # | Ticker | Company | Sector | Price | Insider | MCap |
|---|---|---|---|---|---|---|
| 1 | BFAM | Bright Horizons Family... | Consumer Cyclical | $74.33 | — | $3.9B |
| 2 | BRKR | Bruker Corporation | Healthcare | $59.25 | — | $9.0B |
| 3 | CHKP | Check Point Software T... | Technology | $133.23 | — | $13.6B |
| 4 | CRDO | Credo Technology Group... | Technology | $240.24 | — | $44.8B |
| 5 | CRML | Critical Metals Corp. | Basic Materials | $8.04 | — | $1.2B |
| 6 | CTVA | Corteva, Inc. | Basic Materials | $82.37 | — | $55.1B |
| 7 | CVLT | Commvault Systems, Inc. | Technology | $140.36 | — | $5.8B |
| 8 | DJT | Trump Media & Technolo... | Communication Services | $9.77 | — | $2.7B |
| 9 | EIX | Edison International | Utilities | $73.68 | — | $28.4B |
| 10 | FTNT | Fortinet, Inc. | Technology | $172.78 | — | $126.8B |
| 11 | HIMS | Hims & Hers Health, Inc. | Consumer Defensive | $31.66 | — | $7.1B |
| 12 | KD | Kyndryl Holdings, Inc. | Technology | $13.25 | — | $2.9B |
| 13 | MIAX | Miami International Ho... | Financial Services | $44.05 | — | $4.3B |
| 14 | NNE | Nano Nuclear Energy Inc. | Industrials | $19.24 | — | $1.0B |
| 15 | OKTA | Okta, Inc. | Technology | $172.91 | — | $28.7B |
🔴 Sell Signals (5 of 31 total)
Ranked by RSI (higher RSI for sell signals = more overbought)
| # | Ticker | Company | Sector | Price | Insider | MCap |
|---|---|---|---|---|---|---|
| 1 | ACVA | ACV Auctions Inc. | Consumer Cyclical | $7.22 | — | $1.3B |
| 2 | AES | The AES Corporation | Utilities | $14.71 | — | $10.5B |
| 3 | AIT | Applied Industrial Tec... | Industrials | $338.50 | — | $12.5B |
| 4 | ASND | Ascendis Pharma A/S | Healthcare | $249.36 | — | $15.5B |
| 5 | BBIO | BridgeBio Pharma, Inc. | Healthcare | $78.68 | — | $15.4B |
Field Notes
Sector concentration: Technology (12), Financial Services (10), Consumer Cyclical (7)
Data coverage: 1.9% insider (7d), 0.0% congressional (30d), 0.0% earnings, 11.1% news (7d)
Peer Analysis
BBIO (BridgeBio Pharma, Inc.): Leads 5 peers: RVMD ($221.15), IONS ($62.43), ASND ($249.36), SMMT ($14.33), ROIV ($37.58)
ASND (Ascendis Pharma A/S): Leads 5 peers: IONS ($62.43), BBIO ($78.68), RVMD ($221.15), ROIV ($37.58), SMMT ($14.33)
Recent Headlines
OKTA (Okta, Inc.)
- OKTA Q2 Earnings Beat on Subscription Growth, FY27 View Raised
- Jobless Claims Decreased More Than Expected
Vlad's Take
Today's signals: Strong sector concentration in Technology (12 signals) suggests sector-specific rotation.
Trading tips for this strategy:
- Entry timing: Enter on pullback after crossover or at crossover close price
- Position sizing: Start with 2-3% of portfolio per signal (swing trade size)
- Stop loss: Below recent swing low for buys, above recent swing high for sells
- Take profit: 5-10% target for swings, or trail stop at EMA10
- Time stop: Exit if crossover reverses within 1-2 weeks (failed signal)
Risk warning: EMA crossovers generate more signals but higher whipsaw risk in ranging markets. Use with trend filter (price vs SMA200)
Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.
This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/
📢 Support the project by liking, sharing, or subscribing — it helps more readers discover these signals.